Brief: Vbi Vaccines Inc- Company Has Regained Compliance With Nasdaq Minimum Bid Price Requirement
VBI Vaccines Inc VBIV.O :
* VBI VACCINES INC- COMPANY HAS REGAINED COMPLIANCE WITH
NASDAQ
MINIMUM BID PRICE REQUIREMENT
Source text for Eikon: ID:
Further company coverage: VBIV.O
Recent news on VBI Vaccines
See all newsBrief: VBI Vaccines Provides Update On Its Restructuring Proceedings
Brief: Vbi Vaccines Announces New Tumor Response Data From Ongoing Randomized Controlled Phase 2B Study Of Vbi-1901 In Recurrent Glioblastoma Patients
VBI Vaccines Inc reports results for the quarter ended in March - Earnings Summary
Brief: VBI Vaccines Says Entered At Market Offering Deal For Gross Proceeds Of Up To $8.5 Mln
Brief: VBI Vaccines Q1 Adjusted EPS USD -0.55